REPL
Replimune Group Inc
Price:  
11.44 
USD
Volume:  
876,129.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-1096.1%
Upside

As of 2025-03-16, the Relative Valuation of Replimune Group Inc (REPL) is (113.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.44 USD, the upside of Replimune Group Inc based on Relative Valuation is -1096.1%.

The range of the Relative Valuation is (95.61) - (145.29) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 32.3x - 49.0x 41.9x
Forward P/E multiples 27.6x - 49.8x 35.0x
Fair Price (95.61) - (145.29) (113.96)
Upside -935.8% - -1370.0% -1096.1%
11.44 USD
Stock Price
(113.96) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2025-03-11 -3.75
2025-03-10 -3.76
2025-03-07 -3.88
2025-03-06 -3.96
2025-03-05 -4.15
2025-03-04 -4.06
2025-03-03 -4.09
2025-02-28 -4.28
2025-02-27 -4.26
2025-02-26 -4.47
2025-02-25 -4.55
2025-02-24 -4.59
2025-02-21 -4.72
2025-02-20 -4.83
2025-02-19 -4.65
2025-02-18 -4.73
2025-02-14 -4.76
2025-02-13 -4.82
2025-02-12 -4.65
2025-02-11 -4.34
2025-02-10 -4.43
2025-02-07 -4.70
2025-02-06 -4.74
2025-02-05 -4.81
2025-02-04 -4.73
2025-02-03 -4.63
2025-01-31 -4.72
2025-01-30 -4.60
2025-01-29 -4.75
2025-01-28 -4.73
2025-01-27 -4.62
2025-01-24 -4.59
2025-01-23 -4.64
2025-01-22 -4.39
2025-01-21 -4.00
2025-01-17 -3.42
2025-01-16 -3.50
2025-01-15 -3.52
2025-01-14 -3.54
2025-01-13 -3.67
2025-01-10 -3.73
2025-01-08 -3.89
2025-01-07 -3.78
2025-01-06 -4.06
2025-01-03 -4.26
2025-01-02 -4.24
2024-12-31 -4.09
2024-12-30 -4.16
2024-12-27 -4.14
2024-12-26 -4.32